Jim Cramer reveals the top places to invest new money on the stock market.» Read More
In Wednesday’s Web Extra the traders talk Deere & Co. Find out if this 'ag' name could grow your portfolio. Also Guy Adami has a biotech trade for you.
The Dow fell by triple digits on Tuesday as worries about further losses stemming from the mortgage crisis moved back into the spotlight.
There’s no offense like a good defense. Find out how to keep your cash, even in the worst of times.
Health care stocks have been the stealth performers, and they will likely continue to outperform because of steady earnings, a favorable macro environment and cheap valuations, says Merrill Lynch's Brian Belski.
In the spirit of the Beijing Olympics set to begin on Friday, we thought it would be fun to apply a CNBC twist to the summer games. Which World Market Index is poised to win the gold?
The Dow closed lower on Friday after General Motors reported hefty losses and new data showed U.S. employers cut jobs for the seventh straight month.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Biogen Idec and Elan said on Thursday they have notified regulators of two confirmed cases of a potentially deadly brain disease in multiple sclerosis (MS) patients being treated with Tysabri.
Bristol Myers offered a cool $4.5 billion for ImClone Thursday. Is now the time to play biotech?
Cramer makes the call on viewers' favorite stocks.
With Roche set to scoop up Genentech, which biotech is probably the next blockbuster?
Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.
Pete Najarian reveals 3 biotechs he feels provide the most bang for the buck?
The buyout offer from Swiss drug giant Roche has shares of DNA trading at their highest level in about two-and-a-half years and according to CNBC stock-stat maven, Robert Hum, if they close up at least 8.88% it'll be their biggest one-day percentage gain since April 15, 2005.
In Wednesday’s Web Extra Pete Najarian reveals why he thinks the solar trade is starting to turn. Also “if you want to get into drugs” Guy Adami has your play.
The Dow closed below 11,000 for the first time in two years on Tuesday. What's the "Word on the Street?"
Fearing the two largest U.S. mortgage finance companies need a government bailout, investors pushed stocks lower Friday. What's the "Word On The Street?"
Genentech, the world's biggest biotech, releases its quarterly report on Monday. Will the sector get a boost from DNA earnings?
Nearly 1.5 billion shares and $16.8 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge. Check out the bets being made today...
Big pharma makes strange bedfellows. Pfizer, Merck and Eli Lilly this morning announced they've launched a joint venture of sorts called, "Enlight Biosciences". They're doing it with the help of the Boston-based VC firm PureTech Ventures.